(2020/02/27)
p. 6294 - 6302
(2019/04/25)p. 22490 - 22497
(2018/06/29)p. 1134 - 1143
(2017/08/14)(2017/10/26)
(2016/10/17)
p. 487 - 496
(2016/01/30)p. 629 - 632
(2014/03/21)p. 6990 - 7003
(2013/07/26)p. 435 - 442
(2012/10/07)p. 6041 - 6052
(2012/06/04)p. 1229 - 1237
(2011/11/14)(2011/07/09)
p. 5 - 7
(2009/09/06)p. 13132 - 13141
(2009/12/08)(2009/07/18)
p. 7800 - 7805
(2009/12/07)(2008/06/13)
(2008/06/13)
(2010/11/08)
p. 2771 - 2777
(2007/10/03)p. 2233 - 2237
(2007/10/03)p. 3315 - 3321
(2007/10/03)(2008/06/13)
p. 833 - 837
(2007/10/03)p. 825 - 828
(2007/10/03)(2008/06/13)
p. 721 - 727
(2007/10/03)p. 10662 - 10663
(2007/10/03)p. 717 - 723
(2007/10/02)p. 4301 - 4312
(2007/10/02)p. 895 - 896
(2007/10/02)p. 3344 - 3353
(2007/10/02)(2008/06/13)
(2008/06/13)
(E)-4-hydroxybenzaldehyde oxime
4-methoxy-benzylamine
4-(benzyloxy)benzylamine
hydrogenchloride
ethanol
(4-(tert-butoxy)phenyl)methanamine
C18H28N6O6
(2R)-N-(4-hydroxybenzyl)-2-t-butoxycarbonylamino-3-cyclohexylmethylthiopropanamide
2-chloro-6-[(4-hydroxybenzyl)amino]-9-isopropyl-8-azapurine
(R,S)-N2-(Diphenylacetyl)-N-[(4-hydroxyphenyl)-methyl]-N6-[(phenylmethoxy)carbonyl]-lysinamide